FEBS J 274:21632180 Hicks LM, Cahoon RE, Bonner ER, Rivard RS, Sheffield J, Jez JM (2007) Thiol-based regulation of redox-active glutamate-cysteine ligase from Arabidopsis thaliana
Our study offers novel insights as the first project to link biological consequences of weight loss, namely lower leptin and reduced GLP-1, to eating larger amounts of food, which is a core feature of binge eating, said co-author Lindsay Bodell, a professor in the Department of Psychology at Western University in Ontario, Canada
Patient Assessment Protocol Comprehensive medical history with obesity-specific screening Physical examination including BMI, waist circumference, and body composition analysis Laboratory workup: complete metabolic panel, lipid panel, HbA1c, thyroid function, insulin levels Screening for sleep apnea, PCOS, Cushing syndrome, and other secondary causes of obesity Mental health screening for binge eating disorder and depression Readiness-to-change assessment Medication Formulary for Your Medical Weight Loss Program GLP-1 receptor agonists: Semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Zepbound) Sympathomimetic agents: Phentermine (short-term), phentermine/topiramate (Qsymia) Other FDA-approved options: Naltrexone/bupropion (Contrave), orlistat (Xenical/Alli) Off-label considerations: Metformin, topiramate, bupropion (when clinically appropriate and properly documented) Your medical weight loss program's protocols should specify prescribing criteria, dosing escalation schedules, monitoring requirements, and discontinuation criteria for each medication
Copays and patient responsibility amounts are described as non-refundable
Professional guidance from a GP or HCPC-registered dietitian is recommended before restricting calories if you are under 18, underweight, pregnant, breastfeeding, or managing a medical condition
In the context of gut healing, this local exposure is a significant advantage you wont be able to replicate with an injection
.png)
